Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension
Archives of Internal Medicine2009Vol. 169(13), pp. 1195–1195
Citations Over TimeTop 1% of 2009 papers
Kaycee M. Sink, Xiaoyan Leng, Jeff D. Williamson, Stephen B. Kritchevsky, Kristine Yaffe, Lewis H. Kuller, Sevil Yaşar, Hal H. Atkinson, Mike E. Robbins, Bruce M. Psaty, David C. Goff
Abstract
While ACE inhibitors as a class do not appear to be independently associated with dementia risk or cognitive decline in older hypertensive adults, there may be within-class differences in regard to these outcomes. These results should be confirmed with a randomized clinical trial of a centrally active ACE inhibitor in the prevention of cognitive decline and dementia.
Related Papers
- → Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients(2000)512 cited
- → Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery(2020)40 cited
- → The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis(2021)19 cited
- → The Nursing Home Effect: A Case Study of Residents With Potential Dementia and Emergency Department Visits(2013)7 cited
- → Safety of diuretic administration during the early management of dyspnea patients who are not finally diagnosed with acute heart failure(2020)3 cited